Therapeutic intervention in neurological disorders still relies heavily on pharmacological solutions, while the treatment of patients with drug resistance remains an open challenge. This is particularly true for patients with epilepsy, 30% of whom are refractory to medications. Implantable devices for chronic recording and electrical modulation of brain activity have proved a viable alternative in such cases. To operate, the device should detect the relevant electrographic biomarkers from Local Field Potentials (LFPs) and determine the right time for stimulation. To enable timely interventions, the ideal device should attain biomarker detection with low latency while operating under low power consumption to prolong the battery life. Neuromorphic networks have progressively gained reputation as low-latency low-power computing systems, which makes them a promising candidate as processing core of next-generation implantable neural interfaces. Here we introduce a fully-analog neuromorphic device implemented in CMOS technology for analyzing LFP signals in an in vitro model of acute ictogenesis. We show that the system can detect ictal and interictal events with ms-latency and with high precision, consuming on average 3.50 nW during the task. Our work paves the way to a new generation of brain implantable devices for personalized closed-loop stimulation for epilepsy treatment.
翻译:神经系统紊乱症的治疗干预仍然严重依赖药理解决方案,而药物抗药性患者的治疗仍是一个公开的挑战。对于癫痫患者来说,情况尤其如此,他们中30%的人对药物有耐受力。慢性记录和脑活动电动调节的可移植装置已证明是这类情况下可行的替代方法。要操作,该装置应检测当地外地潜力(LFPs)的相关电动生物标志,并确定正确的刺激时间。为了能够及时采取干预措施,理想装置应能够在低电耗下运行以延长电池寿命的同时,获得低悬浮生物标志检测。神经畸形网络逐渐获得低延迟低能量低能量计算系统的声誉,这使他们成为处理下一代可移植神经界面的核心的有前途的候选者。我们在这里引入了一种完全抗辐射神经形态装置,用于在急性致癌模型中分析LFP信号。我们显示,系统可以在低能量消耗下以低能量消耗力操作延长电池寿命。神经畸形网络逐渐成为低能量的低能低能量计算系统,从而成为了低能量低能量低能量计算系统的名,这使他们成为处理工具,从而成为处理下一代神经活动的一个有希望的候选者,从而成为处理核心核心。在这里,我们可以使用高精密的硬化个人生成工作,在制造中可以进行中可以移动的硬化工作。